Sangamo Therapeutics, Inc. (SGMO) — Analyst estimates
Consensus analyst estimates for Sangamo Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 13.40M | -0.06 | 1 |
| 2027 | 28.80M | -0.02 | 1 |
| 2028 | 264.1M | 0.25 | 1 |
| 2029 | 396.43M | 0.49 | 1 |
| 2030 | 540.07M | 0.76 | 1 |
Consensus analyst estimates by fiscal year.